id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0028-0003,FDA,FDA-2011-D-0028,Medical Devices: Ovarian Adnexal Mass Assessment Score Test System; Labeling; Black Box Restrictions,Rule,Final Rule,2011-12-30T05:00:00Z,2011,12,2011-12-30T05:00:00Z,,2011-12-30T14:31:25Z,2011-33588,0,0,0900006480f8b788
FDA-2011-D-0028-0002,FDA,FDA-2011-D-0028,Class II Special Controls Guidance Document: Ovarian Adnexal Mass Assessment Score Test Sytem - Guidance,Other,GDL-Guidance (Supporting and Related Materials),2011-03-23T04:00:00Z,2011,3,2011-03-23T04:00:00Z,,2024-11-12T04:59:42Z,,1,0,0900006480c0eef9
FDA-2011-D-0028-0001,FDA,FDA-2011-D-0028,Guidance for Industry and Food and Drug Administration Staff; Availability: Class II Special Controls Guidance Document: Ovarian Adnexal Mass Assessment Score Test System,Notice,NAD-Notice of Availability of Data,2011-03-23T04:00:00Z,2011,3,2011-03-23T04:00:00Z,,2011-03-23T16:25:26Z,2011-06622,0,0,0900006480c0ebe4